Bausch Health Americas, Inc.
Bausch Health Americas, Inc., formerly known as Valeant Pharmaceuticals, is a prominent player in the global healthcare industry, headquartered in the United States. Founded in 1983, the company has evolved significantly, focusing on developing, manufacturing, and marketing a diverse range of pharmaceutical products and medical devices. With a strong presence in North America and expanding operations in Europe and other regions, Bausch Health is dedicated to addressing the needs of patients in areas such as dermatology, ophthalmology, and gastrointestinal health. Its core offerings include innovative therapies and advanced medical technologies that set it apart in a competitive market. Recognised for its commitment to quality and patient care, Bausch Health has achieved notable milestones, solidifying its position as a trusted name in healthcare.
DitchCarbon Score
How does Bausch Health Americas, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Americas, Inc.'s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bausch Health Americas, Inc.'s reported carbon emissions
Bausch Health Americas, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is expected to align with industry standards regarding climate commitments, which typically include initiatives aimed at reducing greenhouse gas emissions and enhancing sustainability practices. As the pharmaceutical sector increasingly prioritises environmental responsibility, Bausch Health may be developing strategies to address climate change, although specific details are not provided at this time. In summary, while Bausch Health Americas, Inc. has not disclosed emissions data or reduction targets, the company is likely to be engaged in broader industry efforts to mitigate climate impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Americas, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
